Spruce Biosciences, Inc.
CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS

Abstract:

The present invention provides novel pharmaceutical compositions comprising 3-(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethy- lpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).